Functional relevance of antiemetic control. Experience using the FLIE questionnaire in a randomised study of the NK-1 antagonist aprepitant. (Q44490963)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Functional relevance of antiemetic control. Experience using the FLIE questionnaire in a randomised study of the NK-1 antagonist aprepitant (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

A R Martin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A D Carides

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J D Pearson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Elmer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C Schmidt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

B Cai

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S P Chawla

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S M Grunberg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

1395-1401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

Quality of life consequences of chemotherapy-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

Patients' self-reported functional status after granisetron or ondansetron therapy to prevent chemotherapy-induced nausea and vomiting at six cancer centers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

Quality of life studies in chemotherapy-induced emesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900299-5

7 January 2021

10.1016/S0959-8049(03)00299-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826042%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference